Personalis Operating Expenses 2018-2025 | PSNL
Personalis operating expenses from 2018 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Personalis Annual Operating Expenses
(Millions of US $) |
| 2024 |
$153 |
| 2023 |
$183 |
| 2022 |
$181 |
| 2021 |
$151 |
| 2020 |
$121 |
| 2019 |
$88 |
| 2018 |
$52 |
| 2017 |
$32 |
Personalis Quarterly Operating Expenses
(Millions of US $) |
| 2025-03-31 |
$38 |
| 2024-12-31 |
$35 |
| 2024-09-30 |
$40 |
| 2024-06-30 |
$39 |
| 2024-03-31 |
$38 |
| 2023-12-31 |
$44 |
| 2023-09-30 |
$49 |
| 2023-06-30 |
$42 |
| 2023-03-31 |
$49 |
| 2022-12-31 |
$49 |
| 2022-09-30 |
$42 |
| 2022-06-30 |
$46 |
| 2022-03-31 |
$44 |
| 2021-12-31 |
$41 |
| 2021-09-30 |
$40 |
| 2021-06-30 |
$37 |
| 2021-03-31 |
$33 |
| 2020-12-31 |
$34 |
| 2020-09-30 |
$29 |
| 2020-06-30 |
$29 |
| 2020-03-31 |
$29 |
| 2019-12-31 |
$25 |
| 2019-09-30 |
$23 |
| 2019-06-30 |
$20 |
| 2019-03-31 |
$20 |
| 2018-12-31 |
|
| 2018-09-30 |
$13 |
| 2018-06-30 |
$13 |
| 2017-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.580B |
$0.085B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
